Recombinant Anti-CD22 (Clone hL22 (Epratuzumab))
Applications | Bl, FC, IP |
Reactivities | Human, Monkey |
Conjugation | Unconjugated |
Recombinant Anti-CD22 (Clone hL22 (Epratuzumab))
Applications | Bl, FC, IP |
Reactivities | Human, Monkey |
Conjugation | Unconjugated |
Recombinant Anti-CD64 (Clone H22)
Applications | FC |
Reactivities | Human |
Conjugation | Unconjugated |
Modifications | This chimeric human antibody was made using the variable domain sequences of the original IgG1 format, for improved compatibility with existing reagents, assays and techniques. |
Recombinant Anti-CD80 (Clone IDEC-114 (Galiximab))
Applications | ELISA, FC, IHC, IP, WB |
Reactivities | Human |
Conjugation | Unconjugated |
Recombinant Anti-IL-6 receptor (Clone rhPM-1 (Tocilizumab))
Applications | ELISA |
Reactivities | Human |
Conjugation | Unconjugated |
Modifications | NOT FOR THERAPEUTIC USE - This is a research-grade biosimilar. |
Recombinant Anti-GM2 ganglioside (Clone L55-81)
Applications | ELISA, IHC |
Reactivities | Human |
Conjugation | Unconjugated |
Recombinant Anti-CD40 (Clone 5D12)
Applications | ELISA, FC, IHC, IP |
Reactivities | Human, Monkey, Cynomolgus |
Conjugation | Unconjugated |
Recombinant Anti-desmosome/hemidesmosome (Clone F12)
Applications | IF |
Reactivities | Human |
Conjugation | Unconjugated |
Recombinant Anti-Fas (Clone R-125224)
Applications | ELISA, FC |
Reactivities | Human |
Conjugation | Unconjugated |
Recombinant Anti-Rhesus D antigen (Clone D7C2)
Applications | FC |
Reactivities | Human |
Conjugation | Unconjugated |
USD 523.00
2 Weeks
Recombinant Anti-EGFR (Clone 2F8 (Zalutumumab; HuMax-EGFR))
Applications | ELISA, FC, WB |
Reactivities | Human |
Conjugation | Unconjugated |
Recombinant Anti-CD80 (Clone 16C10)
Applications | ELISA |
Reactivities | Human |
Conjugation | Unconjugated |
Recombinant Anti-BRD4 (Clone RAB-C131)
Applications | ChIP, ELISA, FC, IF |
Reactivities | Human |
Conjugation | His Tag |
Recombinant Anti-CBX5 (Clone RAB-C133)
Applications | ChIP, ELISA |
Reactivities | Human |
Conjugation | His Tag |
Recombinant Anti-CBX1 (Clone RAB-C145)
Applications | ChIP, ELISA, IF |
Reactivities | Human |
Conjugation | His Tag |
Recombinant Anti-PRMT5 (Clone RAB-C136)
Applications | ChIP, ELISA, IF |
Reactivities | Human |
Conjugation | His Tag |
Recombinant Anti-WDR5 (Clone RAB-C223)
Applications | ChIP, ELISA, FC, IF |
Reactivities | Human |
Conjugation | His Tag |
Recombinant Anti-CBX2 (Clone RAB-C238)
Applications | ChIP, ELISA, IF |
Reactivities | Human |
Conjugation | His Tag |
Recombinant Anti-L3MBTL1 (Clone RAB-C213)
Applications | ChIP, ELISA, FC, IF |
Reactivities | Human |
Conjugation | His Tag |
Recombinant Anti-PRDM4 (Clone RAB-C367)
Applications | ChIP, ELISA, IF |
Reactivities | Human |
Conjugation | His Tag |
Recombinant Anti-PRDM9 (Clone RAB-C370)
Applications | ChIP, ELISA, IF |
Reactivities | Human |
Conjugation | His Tag |
Recombinant Anti-PRMT3 (Clone RAB-C372)
Applications | ChIP, ELISA |
Reactivities | Human |
Conjugation | His Tag |
Recombinant Anti-SETD7 (Clone RAB-C220)
Applications | ChIP, ELISA, FC, IF |
Reactivities | Human |
Conjugation | His Tag |
Recombinant Anti-SFMBT1 (Clone RAB-C396)
Applications | ChIP, ELISA |
Reactivities | Human |
Conjugation | His Tag |
Recombinant Anti-TDRD3 (Clone RAB-C419)
Applications | ChIP, ELISA, IF |
Reactivities | Human |
Conjugation | His Tag |
Recombinant Anti-SUV420H2 (Clone RAB-C409)
Applications | ChIP, ELISA |
Reactivities | Human |
Conjugation | His Tag |
Recombinant Anti-FOXP4 (Clone RAB-S40)
Applications | ELISA, FC, IF |
Reactivities | Human |
Conjugation | His Tag |
Recombinant Anti-FOXP1 (Clone RAB-S37)
Applications | ELISA, FC, IF |
Reactivities | Human |
Conjugation | His Tag |
Recombinant Anti-FOXP2 (Clone RAB-S249)
Applications | ELISA, FC |
Reactivities | Human |
Conjugation | His Tag |
Recombinant Anti-PD-L1 (Clone 332M7)
Applications | FC |
Reactivities | Human, Monkey, Mouse |
Conjugation | Unconjugated |
A humanized monoclonal antibody against PDL1 expressed in CHO cells according to Tecentriq sequence
Applications | FC |
Reactivities | Human |
Conjugation | Unconjugated |
USD 420.00
4 Weeks
A humanized monoclonal antibody against PDL1 expressed in CHO cells according to Tecentriq sequence, Biotinylated
Applications | FC |
Reactivities | Human |
Conjugation | Biotin |
USD 420.00
4 Weeks
A humanized monoclonal antibody against PDL1 expressed in CHO cells according to Tecentriq sequence, HRP conjugated
Applications | FC |
Reactivities | Human |
Conjugation | HRP |
A humanized monoclonal antibody against PDL1 expressed in CHO cells according to Tecentriq sequence
Applications | FC |
Reactivities | Human |
Conjugation | Unconjugated |
A humanized monoclonal antibody against PDL1 expressed in CHO cells according to Avelumab sequence
Applications | FC |
Reactivities | Human |
Conjugation | Unconjugated |
USD 420.00
4 Weeks
A humanized monoclonal antibody against PDL1 expressed in CHO cells according to Avelumab sequence, Biotinylated
Applications | FC |
Reactivities | Human |
Conjugation | Biotin |
USD 420.00
4 Weeks
A humanized monoclonal antibody against PDL1 expressed in CHO cells according to Avelumab sequence, HRP conjugated
Applications | FC |
Reactivities | Human |
Conjugation | HRP |
A humanized monoclonal antibody against PDL1 expressed in CHO cells according to Avelumab sequence
Applications | FC |
Reactivities | Human |
Conjugation | Unconjugated |